BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16777497)

  • 1. Cu(II) induces small-size aggregates with amyloid characteristics in two alleles of recombinant ovine prion proteins.
    Tsiroulnikov K; Rezaei H; Dalgalarrondo M; Chobert JM; Grosclaude J; Haertlé T
    Biochim Biophys Acta; 2006 Jul; 1764(7):1218-26. PubMed ID: 16777497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper induces increased beta-sheet content in the scrapie-susceptible ovine prion protein PrPVRQ compared with the resistant allelic variant PrPARR.
    Wong E; Thackray AM; Bujdoso R
    Biochem J; 2004 May; 380(Pt 1):273-82. PubMed ID: 14969585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
    Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
    Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
    Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
    J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osmolyte trimethylamine N-oxide converts recombinant alpha-helical prion protein to its soluble beta-structured form at high temperature.
    Nandi PK; Bera A; Sizaret PY
    J Mol Biol; 2006 Sep; 362(4):810-20. PubMed ID: 16949096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
    Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
    Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational variation between allelic variants of cell-surface ovine prion protein.
    Thackray AM; Yang S; Wong E; Fitzmaurice TJ; Morgan-Warren RJ; Bujdoso R
    Biochem J; 2004 Jul; 381(Pt 1):221-9. PubMed ID: 15070397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of possible prion protein self-interaction domains using peptide arrays.
    Rigter A; Langeveld JP; Timmers-Parohi D; Jacobs JG; Moonen PL; Bossers A
    BMC Biochem; 2007 Apr; 8():6. PubMed ID: 17430579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absolute and relative quantification of sheep brain prion protein (PrP) allelic variants by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry.
    Morel N; Andréoletti O; Grassi J; Clément G
    Rapid Commun Mass Spectrom; 2007; 21(24):4093-100. PubMed ID: 18008391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure.
    Cobb NJ; Sönnichsen FD; McHaourab H; Surewicz WK
    Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18946-51. PubMed ID: 18025469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanopore analysis reveals differences in structural stability of ovine PrP(C) proteins corresponding to scrapie susceptible (VRQ) and resistance (ARR) genotypes.
    Madampage CA; Marciniuk K; Määttänen P; Cashman NR; Potter A; Lee JS; Napper S
    Prion; 2013; 7(6):511-9. PubMed ID: 24401607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembly of recombinant prion protein of 106 residues.
    Baskakov IV; Aagaard C; Mehlhorn I; Wille H; Groth D; Baldwin MA; Prusiner SB; Cohen FE
    Biochemistry; 2000 Mar; 39(10):2792-804. PubMed ID: 10704232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assembly of natural and recombinant prion protein into fibrils.
    Leffers KW; Wille H; Stöhr J; Junger E; Prusiner SB; Riesner D
    Biol Chem; 2005 Jun; 386(6):569-80. PubMed ID: 16006244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformation dependent pro-apoptotic activity of the recombinant human prion protein fragment 90-231.
    Corsaro A; Paludi D; Villa V; D'Arrigo C; Chiovitti K; Thellung S; Russo C; Di Cola D; Ballerini P; Patrone E; Schettini G; Aceto A; Florio T
    Int J Immunopathol Pharmacol; 2006; 19(2):339-56. PubMed ID: 16831301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of divalent cations on elk prion protein fibril formation and stability.
    Samorodnitsky D; Nicholson EM
    Prion; 2018 Jan; 12(1):63-71. PubMed ID: 29310497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detailed biophysical characterization of the acid-induced PrP(c) to PrP(β) conversion process.
    Bjorndahl TC; Zhou GP; Liu X; Perez-Pineiro R; Semenchenko V; Saleem F; Acharya S; Bujold A; Sobsey CA; Wishart DS
    Biochemistry; 2011 Feb; 50(7):1162-73. PubMed ID: 21189021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mechanism of alpha-helix to beta-sheet transition in the recombinant prion protein.
    Morillas M; Vanik DL; Surewicz WK
    Biochemistry; 2001 Jun; 40(23):6982-7. PubMed ID: 11389614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocatalytic conversion of recombinant prion proteins displays a species barrier.
    Baskakov IV
    J Biol Chem; 2004 Feb; 279(9):7671-7. PubMed ID: 14668351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new paradigm for enzymatic control of α-cleavage and β-cleavage of the prion protein.
    McDonald AJ; Dibble JP; Evans EG; Millhauser GL
    J Biol Chem; 2014 Jan; 289(2):803-13. PubMed ID: 24247244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-homocysteinylation of ovine prion protein induces amyloid-like transformation.
    Stroylova YY; Chobert JM; Muronetz VI; Jakubowski H; Haertlé T
    Arch Biochem Biophys; 2012 Oct; 526(1):29-37. PubMed ID: 22782079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.